Chart of Day: Novavax (NVAX) – 5/9

The bird flu story is taking off.

It’s spread among cows, brown bears, skunks, mountain lions, and even a dolphin in Florida. Now, though, we’re seeing reports of a human being infected.

As noted by Bloomberg, “That’s probably only because there is extremely limited testing of people underway to detect it. State governments and farm owners have kept Centers for Disease Control and Prevention teams from conducting on-the-ground investigations that would offer a fuller picture of the prevalence of the virus in humans.”

“The recent patient is recovering after experiencing eye redness as their sole symptom. However, avian flu typically kills half the people known to have been infected, hinting at the danger it poses if it were to spread widely,” they added.

Should we hear more about the bird flu impacting humans, keep an eye on stocks, such as Novavax (SYM: NVAX). According to AOL.com, “Novavax says its proprietary virus-like particle technology can slash weeks off the time needed to produce vaccine, and it’s moving closer to commercializing its flu vaccines.”